Raptor Technologies, a Houston-based company providing safety-focused software to schools, has made an acquisition and announced new investment. Graphic via raptortech.com

A Houston company that provides school safety software to schools across the country has made a strategic acquisition.

Raptor Technologies announced last week that it has acquired United Kingdom-based CPOMS, which provides student safeguarding software to schools in the UK. Raptor reported that the M&A activity follows strategic investments from Chicago-based Thoma Bravo and existing investors JMI Equity, a Maryland-based firm, and New York-based Ares Capital. The terms of the deal were not disclosed.

"We are excited to add CPOMS best-in-class wellbeing products to Raptor's market-leading school safety product suite and to welcome the CPOMS team into the Raptor family," says Gray Hall, CEO of Raptor Technologies, in the press release. "Combining CPOMS software and domain expertise with Raptor further advances our mission to protect every child, every school, every day. We are eager to bring the proven capabilities of CPOMS to the US market and continue advancing CPOMS leadership position in the UK."

Raptor was founded to provide schools with a suite of software that can help implement safety across visitor, volunteer, and emergency management services. The software that the CPOMS platform provides targets reporting abuse, cyberbullying, and more.

"Raptor was the perfect fit for CPOMS. Both companies have dedicated themselves to keeping schools and students safe and share very similar cultures," says John Wild, managing director at CPOMS, in the release. "We at CPOMS are excited about joining the Raptor organization and look forward to the enhanced growth opportunities ahead."

Hall will lead the expanded organization, and Wild will transition to managing director of UK Operations for Raptor and CPOMS.

The acquisition was connected to Raptor's recent funding. The company did not disclose the amount raised.

"School safety needs in the US and UK continue to evolve, with solutions for managing the wellbeing and safety of students being paramount," says Adam Solomon, a principal at Thoma Bravo, in the release. "Through this investment and acquisition, we see tremendous potential for Raptor to extend its market leadership in K-12 school safety and its continued deployment of innovative solutions to schools in the US and UK."

The Houston company was founded in 2003. In 2018, Raptor received investment from JMI Equity.

"Combining CPOMS with Raptor creates a company with unique capabilities to help schools manage the safety and wellbeing of their students," says Bob Nye, general partner at JMI Equity, in the release. "We're excited about this acquisition and the strategic opportunity ahead."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.